|
1
|
Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10.
|
J Virol
|
2002
|
2.05
|
|
2
|
B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease.
|
Emerg Infect Dis
|
2003
|
1.86
|
|
3
|
Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses.
|
Virology
|
2003
|
1.75
|
|
4
|
Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality.
|
J Virol
|
2004
|
1.60
|
|
5
|
Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.
|
J Virol
|
2009
|
1.49
|
|
6
|
Efficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid/DNA adjuvant.
|
J Infect Dis
|
2013
|
1.47
|
|
7
|
Temple monkeys and health implications of commensalism, Kathmandu, Nepal.
|
Emerg Infect Dis
|
2006
|
1.46
|
|
8
|
Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis.
|
J Virol
|
2003
|
1.45
|
|
9
|
Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1.
|
Proc Natl Acad Sci U S A
|
2002
|
1.32
|
|
10
|
Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis.
|
J Virol
|
2002
|
1.29
|
|
11
|
A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism.
|
J Virol
|
2004
|
1.28
|
|
12
|
Protein coding content of the UL)b' region of wild-type rhesus cytomegalovirus.
|
Virology
|
2008
|
1.21
|
|
13
|
Replication of rhesus cytomegalovirus in life-expanded rhesus fibroblasts expressing human telomerase.
|
J Virol Methods
|
2002
|
1.17
|
|
14
|
A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques.
|
J Virol
|
2002
|
1.15
|
|
15
|
Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity.
|
Proc Natl Acad Sci U S A
|
2010
|
1.12
|
|
16
|
Exposure of myeloid dendritic cells to exogenous or endogenous IL-10 during maturation determines their longevity.
|
J Immunol
|
2007
|
1.12
|
|
17
|
Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.
|
J Gen Virol
|
2003
|
1.10
|
|
18
|
Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.
|
Adv Virus Res
|
2008
|
1.10
|
|
19
|
A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.
|
J Virol
|
2012
|
1.09
|
|
20
|
Simultaneous detection of antibodies to six nonhuman-primate viruses by multiplex microbead immunoassay.
|
Clin Vaccine Immunol
|
2006
|
1.07
|
|
21
|
Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.
|
J Virol
|
2006
|
1.06
|
|
22
|
Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog.
|
Virology
|
2009
|
1.04
|
|
23
|
Open reading frames carried on UL/b' are implicated in shedding and horizontal transmission of rhesus cytomegalovirus in rhesus monkeys.
|
J Virol
|
2011
|
1.02
|
|
24
|
A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus.
|
Vaccine
|
2008
|
0.98
|
|
25
|
Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.
|
J Virol
|
2010
|
0.95
|
|
26
|
Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques.
|
Med Microbiol Immunol
|
2008
|
0.95
|
|
27
|
Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1.
|
J Virol
|
2012
|
0.94
|
|
28
|
Sequencing the transcriptome of milk production: milk trumps mammary tissue.
|
BMC Genomics
|
2013
|
0.92
|
|
29
|
Functional genetic analysis of rhesus cytomegalovirus: Rh01 is an epithelial cell tropism factor.
|
J Virol
|
2007
|
0.92
|
|
30
|
Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).
|
J Gen Virol
|
2006
|
0.91
|
|
31
|
Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.
|
Vet Microbiol
|
2006
|
0.89
|
|
32
|
Patterns of acute rhesus cytomegalovirus (RhCMV) infection predict long-term RhCMV infection.
|
J Virol
|
2012
|
0.85
|
|
33
|
Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.
|
PLoS One
|
2012
|
0.84
|
|
34
|
Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model.
|
Vaccine
|
2011
|
0.84
|
|
35
|
Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus.
|
PLoS One
|
2011
|
0.83
|
|
36
|
Molecular characterization of Encephalitozoon intestinalis (Microspora) replication kinetics in a murine intestinal cell line.
|
J Eukaryot Microbiol
|
2003
|
0.81
|
|
37
|
Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidazole nucleosides.
|
Antimicrob Agents Chemother
|
2004
|
0.81
|
|
38
|
Vaccination against a virus-encoded cytokine significantly restricts viral challenge.
|
J Virol
|
2013
|
0.81
|
|
39
|
Rhesus brain microvascular endothelial cells are permissive for rhesus cytomegalovirus infection.
|
J Gen Virol
|
2005
|
0.80
|
|
40
|
Human herpes simplex virus type 1 in confiscated gorilla.
|
Emerg Infect Dis
|
2014
|
0.79
|
|
41
|
Pathogen manipulation of cIL-10 signaling pathways: opportunities for vaccine development?
|
Curr Top Microbiol Immunol
|
2014
|
0.78
|
|
42
|
Properties of virion transactivator proteins encoded by primate cytomegaloviruses.
|
Virol J
|
2009
|
0.78
|
|
43
|
Use of specific-pathogen-free (SPF) rhesus macaques to better model oral pediatric cytomegalovirus infection.
|
J Med Primatol
|
2012
|
0.77
|
|
44
|
Mamu-A01/K(b) transgenic and MHC Class I knockout mice as a tool for HIV vaccine development.
|
Virology
|
2009
|
0.76
|
|
45
|
SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaques.
|
Retrovirology
|
2011
|
0.76
|
|
46
|
Exploiting the natural history of cytomegalovirus to vaccinate against HIV.
|
Expert Rev Vaccines
|
2009
|
0.75
|
|
47
|
Occult pretransplantation systemic inflammation and posttransplantation vascular changes in a primate arterial allograft model.
|
Transplantation
|
2004
|
0.75
|
|
48
|
Expression of recipient cytomegalovirus in immunosuppressed and xenotransplanted Macaca fascicularis may be related to more severe gastrointestinal lesions.
|
Xenotransplantation
|
2015
|
0.75
|